238 related articles for article (PubMed ID: 24358274)
21. Effect of Bortezomib on Angiotensin Ⅱ-induced Abdominal Aortic Aneurysm in ApoE
Li F; Li H; Tian C; Nie H; Zheng Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Feb; 39(1):120-127. PubMed ID: 28270294
[TBL] [Abstract][Full Text] [Related]
22. Tauroursodeoxycholic Acid Attenuates Angiotensin II Induced Abdominal Aortic Aneurysm Formation in Apolipoprotein E-deficient Mice by Inhibiting Endoplasmic Reticulum Stress.
Qin Y; Wang Y; Liu O; Jia L; Fang W; Du J; Wei Y
Eur J Vasc Endovasc Surg; 2017 Mar; 53(3):337-345. PubMed ID: 27889204
[TBL] [Abstract][Full Text] [Related]
23. Zoledronate attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of Rho/ROCK-dependent JNK and NF-κB pathway.
Tsai SH; Huang PH; Peng YJ; Chang WC; Tsai HY; Leu HB; Chen JW; Lin SJ
Cardiovasc Res; 2013 Dec; 100(3):501-10. PubMed ID: 24225494
[TBL] [Abstract][Full Text] [Related]
24. The molecular mechanism of Ang II induced-AAA models based on proteomics analysis in ApoE
Ren J; Wu L; Wu J; Tang X; Lv Y; Wang W; Li F; Yang D; Liu C; Zheng Y
J Proteomics; 2022 Sep; 268():104702. PubMed ID: 35988846
[TBL] [Abstract][Full Text] [Related]
25. Deficiency of cathepsin S attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice.
Qin Y; Cao X; Guo J; Zhang Y; Pan L; Zhang H; Li H; Tang C; Du J; Shi GP
Cardiovasc Res; 2012 Dec; 96(3):401-10. PubMed ID: 22871592
[TBL] [Abstract][Full Text] [Related]
26. DOCK2 Deficiency Attenuates Abdominal Aortic Aneurysm Formation-Brief Report.
Guo X; Cai D; Dong K; Li C; Xu Z; Chen SY
Arterioscler Thromb Vasc Biol; 2023 Jun; 43(6):e210-e217. PubMed ID: 37021575
[TBL] [Abstract][Full Text] [Related]
27. Inhibiting the Th17/IL-17A-related inflammatory responses with digoxin confers protection against experimental abdominal aortic aneurysm.
Wei Z; Wang Y; Zhang K; Liao Y; Ye P; Wu J; Wang Y; Li F; Yao Y; Zhou Y; Liu J
Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2429-38. PubMed ID: 25234817
[TBL] [Abstract][Full Text] [Related]
28. CD147 monoclonal antibody attenuates abdominal aortic aneurysm formation in angiotensin II-Infused apoE
Xu C; Liu X; Yu L; Fang X; Yao L; Lau H; Vyas P; Pryke L; Xu B; Tang L; Jiang J; Chen X
Int Immunopharmacol; 2023 Sep; 122():110526. PubMed ID: 37393837
[TBL] [Abstract][Full Text] [Related]
29. Gasdermin D Inhibitor Necrosulfonamide Alleviates Angiotensin II-Induced Abdominal Aortic Aneurysms in Apolipoprotein E-Deficient Mice.
Guo J; Zhang Q; Li Z; Qin M; Shi J; Wang Y; Ai W; Ju J; Samura M; Tsao PS; Xu B
Biomolecules; 2024 Jun; 14(6):. PubMed ID: 38927129
[TBL] [Abstract][Full Text] [Related]
30. Prevention of abdominal aortic aneurysm by anti-microRNA-712 or anti-microRNA-205 in angiotensin II-infused mice.
Kim CW; Kumar S; Son DJ; Jang IH; Griendling KK; Jo H
Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1412-21. PubMed ID: 24812324
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of Notch1-mediated inflammation by intermedin protects against abdominal aortic aneurysm via PI3K/Akt signaling pathway.
Ni XQ; Zhang YR; Jia LX; Lu WW; Zhu Q; Ren JL; Chen Y; Zhang LS; Liu X; Yu YR; Jia MZ; Ning ZP; Du J; Tang CS; Qi YF
Aging (Albany NY); 2021 Feb; 13(4):5164-5184. PubMed ID: 33535178
[TBL] [Abstract][Full Text] [Related]
32. β-Arrestin-2 deficiency attenuates abdominal aortic aneurysm formation in mice.
Trivedi DB; Loftin CD; Clark J; Myers P; DeGraff LM; Cheng J; Zeldin DC; Langenbach R
Circ Res; 2013 Apr; 112(9):1219-29. PubMed ID: 23524589
[TBL] [Abstract][Full Text] [Related]
33. Testosterone Metabolite 6β-Hydroxytestosterone Contributes to Angiotensin II-Induced Abdominal Aortic Aneurysms in
Mukherjee K; Pingili AK; Singh P; Dhodi AN; Dutta SR; Gonzalez FJ; Malik KU
J Am Heart Assoc; 2021 Apr; 10(7):e018536. PubMed ID: 33719500
[TBL] [Abstract][Full Text] [Related]
34. Deficiency of Endogenous Acute-Phase Serum Amyloid A Protects apoE-/- Mice From Angiotensin II-Induced Abdominal Aortic Aneurysm Formation.
Webb NR; De Beer MC; Wroblewski JM; Ji A; Bailey W; Shridas P; Charnigo RJ; Noffsinger VP; Witta J; Howatt DA; Balakrishnan A; Rateri DL; Daugherty A; De Beer FC
Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1156-65. PubMed ID: 25745063
[TBL] [Abstract][Full Text] [Related]
35. Itaconate prevents abdominal aortic aneurysm formation through inhibiting inflammation via activation of Nrf2.
Song H; Xu T; Feng X; Lai Y; Yang Y; Zheng H; He X; Wei G; Liao W; Liao Y; Zhong L; Bin J
EBioMedicine; 2020 Jul; 57():102832. PubMed ID: 32574955
[TBL] [Abstract][Full Text] [Related]
36. Heat shock protein 90 inhibition by 17-DMAG attenuates abdominal aortic aneurysm formation in mice.
Qi J; Yang P; Yi B; Huo Y; Chen M; Zhang J; Sun J
Am J Physiol Heart Circ Physiol; 2015 Apr; 308(8):H841-52. PubMed ID: 25637544
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin-(1-7) mitigated angiotensin II-induced abdominal aortic aneurysms in apolipoprotein E-knockout mice.
Xue F; Yang J; Cheng J; Sui W; Cheng C; Li H; Zhang M; Zhang J; Xu X; Ma J; Lu L; Xu J; Zhang M; Zhang Y; Zhang C
Br J Pharmacol; 2020 Apr; 177(8):1719-1734. PubMed ID: 31658493
[TBL] [Abstract][Full Text] [Related]
38. Fasudil, a Rho-kinase inhibitor, attenuates angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice by inhibiting apoptosis and proteolysis.
Wang YX; Martin-McNulty B; da Cunha V; Vincelette J; Lu X; Feng Q; Halks-Miller M; Mahmoudi M; Schroeder M; Subramanyam B; Tseng JL; Deng GD; Schirm S; Johns A; Kauser K; Dole WP; Light DR
Circulation; 2005 May; 111(17):2219-26. PubMed ID: 15851596
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of EP4 signaling attenuates aortic aneurysm formation.
Yokoyama U; Ishiwata R; Jin MH; Kato Y; Suzuki O; Jin H; Ichikawa Y; Kumagaya S; Katayama Y; Fujita T; Okumura S; Sato M; Sugimoto Y; Aoki H; Suzuki S; Masuda M; Minamisawa S; Ishikawa Y
PLoS One; 2012; 7(5):e36724. PubMed ID: 22570740
[TBL] [Abstract][Full Text] [Related]
40. Role of myeloperoxidase in abdominal aortic aneurysm formation: mitigation by taurine.
Kim HW; Blomkalns AL; Ogbi M; Thomas M; Gavrila D; Neltner BS; Cassis LA; Thompson RW; Weiss RM; Lindower PD; Blanco VM; McCormick ML; Daugherty A; Fu X; Hazen SL; Stansfield BK; Huo Y; Fulton DJ; Chatterjee T; Weintraub NL
Am J Physiol Heart Circ Physiol; 2017 Dec; 313(6):H1168-H1179. PubMed ID: 28971841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
